1-20 of 42
Anne Banos, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of a Combination of Vosaroxin (VOS) and Intermediate-Dose Cytarabine (IDAC) with Idac for the Consolidation Therapy of Younger Patients with Favorable- and Intermediate-Risk Acute Myeloid Leukemia (AML) in First Complete Remission (CR): Preliminary Results of a Randomized Phase 2 R4-VOS Study of the French ALFA-Filo AML Intergroup

Norbert Vey, MD, Corentin Orvain, MD PhD, Christian Recher, MD PhD, Arnaud Pigneux, MD PhD, Marc Bernard, MD, Anne Banos, MD, Pierre Peterlin, MD, Sylvain Chantepie, MD, Xavier Thomas, MD PhD, Cecile Pautas, MD, Claude Gardin, Emilie Lemasle, MD, Emmanuel Raffoux, MD, Romain Guieze, MD, Chantal Himberlin, MD, Clémence Loiseau, MD, Amine Belhabri, MD, Isabelle Luquet, MD, Christine Terré, PharmD, PhD, Martin Carre, MD, Claude Preudhomme, MD PhD, Eric Delabesse, MD PhD, Karine Celli-Lebras, CRA, Ariane C Mineur, CRA, Jean-Francois Brasme, MD PhD, Jean Francois Hamel, MD, Hervé Dombret, MD, Mathilde Hunault, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-137032
Published: 2020
Journal Articles

Very Long Term Follow up a Phase II Study of Post-Remission Subcutaneous (SC) Azacitidine (AZA) in Patients with AML Post-MDS or Higher-Risk (HR) MDS

Amina Cherait, Thorsten Braun, MD PhD, Krimo Bouabdallah, MD, Denis Caillot, Agnès Guerci, MD PhD, Emmanuel Raffoux, MD, Jean Pierre Marolleau, Cecile Pautas, MD, Anne Banos, MD, Chantal Himberlin, MD, Anne Laure Taksin, Arnaud Pigneux, MD PhD, Xavier Thomas, MD PhD, Norbert Vey, MD, Sylvie Chevret, MDPhD, Herve Dombret, MD PhD, Fatiha Chermat, Lionel Ades, MDPhD, Claude Gardin, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-137012
Published: 2020
Journal Articles

SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine Demonstrates a High Complete Response Rate and a Rapid Onset of Response in RARA-Positive Newly Diagnosed Unfit Acute Myeloid Leukemia

Stephane De Botton, Thomas Cluzeau, MDPhD, Carlos Enrique Vigil, MD, Rachel J. Cook, MD, Philippe Rousselot, MDPhD, David A Rizzieri, MD, Jane L. Liesveld, MD, Pierre Fenaux, MD PhD, Thorsten Braun, MD PhD, Anne Banos, MD, Michael R. Savona, MD, Don Park, MD, Michael J. Kelly, MD MPH, MS, Angela Volkert, Li Zhou, PhD, Qing Kang-Fortner, PhD, David A. Roth, MD, Eytan M. Stein, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-134600
Published: 2020
Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Olivier Tournilhac, MD PhD, Maya Hacini, MD, Kamal Bouabdallah, MD, Kamel Laribi, MD, Marie Maerevoet, MD, Loic Ysebaert, MD PhD, Stephanie Guidez, Steven Le Gouill, MD PhD, Marc André, MD, Jehan Dupuis, MD, Catherine Thieblemont, MD PhD, Emmanuel Bachy, MD PhD, Nicolas Daguindau, MD, Franck Morschhauser, MD PhD, Sabine Tricot, MD, Pierre Feugier, MD PhD, Anne Banos, MD, Thierry Lamy De La Chapelle, MD PhD, Adrien Chauchet, MD, Emmanuel Gyan, MD PhD, Guillaume Cartron, MD PhD, Hassan Farhat, MD, Vincent Camus, Bernard Drenou, MD PhD, Hacene Zerazhi, MD, David Sibon, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Caroline Delette, MD, Sylvia Snauwaert, MD, Nicole Straetmans, MD, Richard Delarue, MD, Marie Parrens, MD, Céline Bossard, MD, Laurence De Leval, MD, Philippe Gaulard, MD PhD, Gandhi Laurent Damaj, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-139224
Published: 2020
Journal Articles

Maintenance of Long-Term Undetectable Minimal Residual Disease after Combination of Ibrutinib with Abbreviated Chemotherapy in the Icll-07 Filo Trial

Anne-Sophie Michallet, MD PhD, Marie-Sarah Dilhuydy, MD, Fabien Subtil, Valérie Rouille, Beatrice Mahe, MD, Kamel Laribi, MD, Bruno Villemagne, MD, Gilles A. Salles, MD PhD, Olivier Tournilhac, Alain Jacques Delmer, MD PhD, Christelle Portois, Brigitte Pegourie, MD, Veronique Leblond, MD PhD, Cecile Tomowiak, MD, Sophie de Guibert, MD, Frederique Orsini, Anne Banos, MD, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, MD PhD, Loic Ysebaert, MD PhD, Caroline Dartigeas, MD, Margot Truchan, Jean Pierre Vilque, Thérèse Aurran, MD, Florence Cymbalista, MD PhD, Stephane Lepretre, Vincent Levy, MD PhD, Florence Nguyen-Khac, MD PhD, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Remi Letestu, Pierre Feugier, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3038.
https://doi.org/10.1182/blood-2019-126720
Published: 2019
Journal Articles

Aplastic Anemia in the Elderly: A Nationwide Survey on Behalf of the French Reference Center for Aplastic Anemia

Adrien Contejean, MD, Matthieu Resche-Rigon, MD PhD, Jérôme Tamburini, MD PhD, Marion Alcantara, MD, Fabrice Jardin, MD PhD, Etienne Lengline, MD, Lionel Ades, MD PhD, Didier Bouscary, MDPhD, Ambroise Marçais, MD PhD, Delphine Lebon, MD, Cécile Moluçon-Chabrot, MD PhD, Louis Terriou, MD, Fiorenza Barraco, MD, Anne Banos, MD, Lucile Bussot, Jean-Yves Cahn, MD PhD, Pierre Hirsch, MDPhD, Natacha Maillard, MD, Laurence Simon, MD, Luc Mathieu Fornecker, Gerard Socie, MD PhD, Regis Peffault De Latour, Flore Sicre De Fontbrune, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1298.
https://doi.org/10.1182/blood-2018-99-113359
Published: 2018
Journal Articles

Acute Myeloblastic Leukemia Relapse after Allogeneic Stem Cell Transplantation

Mediavilla Clémence, Stéphane Vigouroux, Reza Tabrizi, MD, Laurence Clement, Anne Banos, MD, Pascal Turlure, MD, Xavier Lafarge, Pierre-Yves Dumas, MD, Thibaut Leguay, MD, Arnaud Pigneux, MD PhD, Noel Milpied, MD, Edouard Forcade, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5737.
https://doi.org/10.1182/blood-2018-99-119021
Published: 2018
Journal Articles

High Rate of Complete Response (CR) with Undetectable Bone Marrow Minimal Residual Disease (MRD) after Chemo-Sparing and MRD-Driven Strategy for Untreated Fit CLL Patients: Final Results of the Icll 07 Filo Trial

Anne-Sophie Michallet, MD PhD, Marie-Sarah Dilhuydy, MD, Fabien Subtil, Valérie Rouille, Beatrice Mahe, MD, Kamel Laribi, MD, Bruno Villemagne, Gilles Andre Salles, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Christelle Portois, Brigitte Pegourie, MD, Véronique Leblond, MD PhD, Cecile Tomowiak, MD, Sophie de Guibert, MD, Frederique Orsini, Anne Banos, MD, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, MD PhD, Caroline Dartigeas, Margot Truchan, Thérèse Aurran, MD, Florence Cymbalista, MD, Stéphane Leprêtre, MD, Vincent Levy, MD PhD, Florence Nguyen-Khac, MD PhD, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Remi Letestu, Pierre Feugier
Journal: Blood
Blood (2018) 132 (Supplement 1): 1858.
https://doi.org/10.1182/blood-2018-99-111977
Published: 2018
Journal Articles

Time to Improve Bortezomib and Lenalidomide Lines of Therapy

Stephanie Guidez, Hélène Demarquette, Denis Caillot, MD, Artur J. Jurczyszyn, MD PhD, Brigitte Pegourie, MD, Marie Lorraine Chretien, Charles Lancesseur, Lionel Karlin, MD, Cristina Joao, MD PhD MSc, Valentine Richez, MD, Laurent Garderet, MD PhD, Souhila Ikhlef, Bruno Royer, MD, Cyrille Hulin, MD, Anne Banos, MD, Eric Voog, MD, Anne-Marie Stoppa, MD, Lofti Benboubker, MD, Niels Abildgaard, MD, Katell Le Du, Philippe Moreau, MDPhD, Thierry Facon, MD, Sonja Zweegman, MD PhD, Margaret Macro, MD, Francesca Marianatal Gay, Evangelos Terpos, MD PhD, Xavier Leleu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1853.
https://doi.org/10.1182/blood.V130.Suppl_1.1853.1853
Published: 2017
Journal Articles

Phase II, Multicenter Trial, Exploring "Chemo-Sparing" Strategy Associating Obinutuzumab+Ibrutinib Followed By a MRD Driven Strategy, in Previously Untreated Symptomatic Medically Fit Chronic Lymphocytic Leukemia Patients (CLL): Preliminary Results of the Induction Phase of the Icll-07 Filo Study

Anne-Sophie Michallet, MD PhD, Marie-Sarah Dilhuydy, MD, Fabien Subtil, Valérie Rouille, Beatrice Mahe, MD, Kamel Laribi, Bruno Villemagne, Gilles Andre Salles, MD PhD, Olivier Tournilhac, MD PhD, Alain Jacques Delmer, MD, Christelle Portois, Brigitte Pegourie, MD, Veronique Leblond, Cecile Tomowiak, MD, Sophie de Guibert, Frederique Orsini, Anne Banos, MD, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, MD PhD, Caroline Dartigeas, Margot Truchan, Thérèse Aurran, MD, Florence Cymbalista, MD, Stéphane Leprêtre, MD, Vincent Levy, MD PhD, Florence Nguyen Khac, Magali Le Garff-Tavernier, Carmen Aanaei, Michel Ticchioni, Remi Letestu, Pierre Feugier, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 497.
https://doi.org/10.1182/blood.V130.Suppl_1.497.497
Published: 2017
Journal Articles

Addition of Lomustine in the Treatment of Elderly Patients with Acute Myeloblastic Leukemia Improves Survival with Acceptably Increased Infectious Toxicity. a Filo Study

Pilar Gallego-Hernanz, MD, Marie C Bene, PharmSciD, PhD, Pierre-Yves Dumas, MD, Jacques Delaunay, MD, Caroline Bonmati, MD, Romain Guieze, MD PhD, Isabelle Luquet, MD, Pascale Cornillet-Lefebvre, Eric Delabesse, MDPhD, Jean-Christophe Ianotto, MD, Mario Ojeda, MD, Mathilde Hunault, MD PhD, Anne Banos, MD, Bruno Lioure, MD, Marc Bernard, MD, Eric Jourdan, MD, Norbert Vey, Hacene Zerazhi, Yosr Hicheri, Ariane C Mineur, Roselyne Delepine, Jean Yves Cahn, MD PhD, Norbert Ifrah, MD, Christian Recher, MD PhD, Arnaud Pigneux, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2587.
https://doi.org/10.1182/blood.V130.Suppl_1.2587.2587
Published: 2017
Journal Articles

Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (≥ 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentric GOELAMS Trial

Mathilde Hunault, MD PhD, Nathalie Maillard, MD, Aline Tanguy-Schmidt, MD, Chantal Himberlin, MD, Bachra Choufi, MD, Caroline Bonmati, MD, Marie Anne Couturier, MD, Eric Deconinck, MD PhD, Jean Pierre Marolleau, MD PhD, Frédérique Orsini-Piocelle, MD, Jacques Delaunay, MD, Emmanuelle Tavernier, MD, Christian Récher, MDPhD, Severine Lissandre, MD, Mario Ojeda-Uribe, MD, Laurence Sanhes, MD, Laurent Sutton, MD, Anne Banos, MD, Bruno Lioure, MD, Marc Bernard, MD, Didier Bouscary, MDPhD, Alain Saad, MD, Valérie Rouille, Philippe Guardiola, MD, Isabelle Luquet, MD, Marie C Bene, PharmSciD, PhD, Francois Dreyfus, MD, Jean-Yves Cahn, MD, Arnaud Pigneux, Norbert Ifrah, MD
Journal: Blood
Blood (2015) 126 (23): 3787.
https://doi.org/10.1182/blood.V126.23.3787.3787
Published: 2015
Journal Articles

Cell-of-Origin (COO) Classification, BCL2 and MYC Expression Associated-Outcome in Younger Patients Treated By RCHOP Front-Line Therapy Versus Intensive Regimen Followed By Autologous Transplant for De Novo Advanced Diffuse Large B Cell Lymphoma (DLBCL) : Results of the French Prospective Multicenter Randomized Trial Goelams -075

Gaëlle Labouré, Marie-Cécile Parrens, MD, Anjarasoa Tsaranazy, Magali Bordier, Steven Le Gouill, MD PhD, Vincent Delwail, MD, Remy Gressin, MD, Jérôme Cornillon, MD, Gandhi Damaj, MD PhD, Charles Yves Foussard, MD, Herve Maisonneuve, MD, Eric Deconinck, MD PhD, Guillaume Cartron, MD PhD, Francois Dreyfus, MD, Emmanuel Gyan, MD PhD, Laurent Sutton, MD, Nadine Morineau, MD, Magda Alexis, Anne Banos, MD, Diane Damotte, MD PhD, Anne Moreau, MD, Françoise Kraeber-Bodéré, MD PhD, Delphine Rossille, PhD, Thierry Fest, MD PhD, Thierry Lamy, MD PhD, Noel Milpied, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3920.
https://doi.org/10.1182/blood.V126.23.3920.3920
Published: 2015
Journal Articles

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Arnaud Pigneux, Christian Recher, MDPhD, Marie C Bene, PharmSciD, PhD, Julien Asselineau, PhD, Ariane C. Mineur, Thibaut Leguay, MD, Jacques Delaunay, MD, Caroline Bonmati, MD, Romain Guieze, MD, Isabelle Luquet, MD, Pascale Cornillet-Lefebvre, MD, Catherine Lacombe, MDPhD, jean-Christophe Ianotto, MD, Mario Ojeda, MD, Mathilde Hunault, MDPhD, Anne Banos, MD, Bruno Lioure, MD, Marc Bernard, MD, Eric Jourdan, MDPhD, Norbert Vey, Hacene Zerazhi, MD, Hichri Yosr, MD, Roselyne Delepine, Rachid Salmi, MDPhD, Francois Dreyfus, MD, Jean-Yves Cahn, Norbert Ifrah, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3736.
https://doi.org/10.1182/blood.V126.23.3736.3736
Published: 2015
Journal Articles

Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma (eNDMM) from Thalidomide

Hélène Demarquette, Stéphanie Guidez, Artur J. Jurczyszyn, MD PhD, Denis Caillot, Brigitte Pegourie, MD, Marie Lorraine Chretien, Charles Lancesseur, Lionel Karlin, Cristina M. Joao, MD PhD, Claire Bories, Laurence Legros, MD, Laurent Garderet, MD, Souhila Ikhlef, Martine Escoffre, Bruno Royer, MD, Laurent Voillat, Cyrille Hulin, Anne Banos, MD, Eric G. Voog, MD, Anne-Marie Stoppa, MD, Lofti Benboubker, Niels Abildgaard, MD Professor, Katell Le Du, Philippe Moreau, Thierry Facon, Sonja Zweegman, MD PhD, Margaret MACRO, MD, Francesca Gay, Evangelos Terpos, Xavier Leleu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4245.
https://doi.org/10.1182/blood.V126.23.4245.4245
Published: 2015
Journal Articles

Salvage Therapy Post Pomalidomide-Based Regimen in Relapsed/Refractory Myeloma

Guillemette Fouquet, Lionel Karlin, Margaret MACRO, MD, Denis Caillot, Murielle Roussel, Bertrand Arnulf, Brigitte Pégourie, Marie-Odile Petillon, Gerald Marit, Claire Mathiot, MD, Brigitte Kolb, Anne-Marie Stoppa, MD, Sabine Brechignac, MD, Philippe Rodon, MD, Mamoun Dib, Mourad Tiab, MD, Laurence Legros, MD, Anne Banos, MD, Marc Wetterwald, MD PhD, Laurent Garderet, MD, Bruno Royer, MD, Cyrille Hulin, Lotfi Benboubker, Olivier Decaux, MD PhD, Martine Escoffre, Jean-Paul Fermand, Philippe Moreau, Herve Avet-Loiseau, MD PhD, Michel Attal, Thierry Facon, Xavier Leleu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1831.
https://doi.org/10.1182/blood.V126.23.1831.1831
Published: 2015
Journal Articles

R-CHOP with or without Radiotherapy in Non-Bulky Limited-Stage Diffuse Large B Cell Lymphoma (DLBCL): Preliminary Results of the Prospective Randomized Phase III 02-03 Trial from the Lysa/Goelams Group

Thierry Lamy, MD PhD, Gandhi Damaj, MD, Emmanuel Gyan, MD PhD, Pierre Soubeyran, MDPhD, Krimo Bouabdallah, MD, Guillaume Cartron, MD, Remy Gressin, MD, Jérôme Cornillon, MD, Anne Banos, MD, Marie-Pierre Moles, MD, Katell Le Dû, Mohamed Benchalal, MD, Valerie Costes, MD, Marie-Christine Bene, MD, Vincent Delwail, MD
Journal: Blood
Blood (2014) 124 (21): 393.
https://doi.org/10.1182/blood.V124.21.393.393
Published: 2014
Journal Articles

Hevylite® to Monitor Response to Therapy in Multiple Myeloma

Guillemette Fouquet, MD, Susanna Schraen, MD, Jean-Luc Faucompré, MD, Lionel Karlin, Margaret Macro, MD, Cyrille Hulin, MD, Brigitte Onraed, MD, Laurent Garderet, MD, Murielle Roussel, MD, Bertrand Arnulf, Brigitte Pegourie, MD, Brigitte Kolb, Anne-Marie Stoppa, MD, Sabine Brechignac, MD, Mauricette Michallet, MD PhD, Gerald Marit, Claire Mathiot, MD, Anne Banos, MD, Mourad Tiab, MD, Mamoun Dib, Jean-Gabriel Fuzibet, MD, Marie-Odile Petillon, MD, Philippe Rodon, MD, Marc Wetterwald, MD PhD, Bruno Royer, MD, Laurence Legros, MD, Lofti Benboubker, MD, Olivier Decaux, Denis Caillot, MD, Martine Escoffre-Barbe, MD, Jean-Paul Fermand, MD, Philippe Moreau, MD, Michel Attal, Hervé Avet-Loiseau, Thierry Facon, MD, Xavier Leleu, MD
Journal: Blood
Blood (2014) 124 (21): 2021.
https://doi.org/10.1182/blood.V124.21.2021.2021
Published: 2014
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

Time to Spare Newly Diagnosed Non Transplant Eligible Myeloma from Thalidomide

Denis Caillot, MD, Muriel Newingerm, MD, Margaret Macro, MD, Brigitte Pegourie, MD, Lionel Karlin, MD, Francesca Gay, MD, Claire Bories, MD, Laurence Legros, MD PhD, Laurent Garderet, MD, Souhila Ikhlef, MD, Martine Escoffre-Barbe, MD, Bruno Royer, MD, Laurent Voillat, MD, Cyrille Hulin, MD, Anne Banos, MD, Eric G. Voog, MD, Anne-Marie Stoppa, MD, Lotfi Benboubker, MD PhD, Eva De Jongh, Sonja Zweegman, MDPhD, Niels Abildgaard, MD, Katell Le Dû, Artur J. Jurczyszyn, MD PhD, Philippe Moreau, MD, Thierry Facon, MD, Evangelos Terpos, Xavier Leleu, MD, Catherine Vieira Dos Santos, Helene Demarquette, MD
Journal: Blood
Blood (2014) 124 (21): 5702.
https://doi.org/10.1182/blood.V124.21.5702.5702
Published: 2014